Corp. Note AUROBINDO PHARMA LTD. - 524804 - Reg. 34 (1) Annual Report. BSE India Further to our letter dated July 7, 2022 intimating the date of 35th Annual General Meeting (AGM) of the Members of the Company and pursuant to Regulation 34 of the SESI (Listing Obligation and Disclosure Requirements) Regulations 2015, please find enclosed Annual Report for the financial year 2021-22 along with Notice of 35th AGM of the Company to be held on Tuesday, August 2, 2022 at 3.30 p.m. IST through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM") which is being sent to the shareholders of the Company through electronic mode. The Annual Report containing the Notice is also being uploaded on the Company''s website https://www.aurobindo.com/investors/results-reports-presentations/annual-reports/. Further, e-voting facility for the AGM will be made available to all the Members of the Company. Commencement of remote e-voting: Friday, July 29, 2022 at 9.00 a.m. End of remote e-voting: Monday, August 1, 2022 at 5.00 p.m. Cut-off date: Tuesday, July 26, 2022